Pemgarda Side Effects
Generic name: pemivibart
Medically reviewed by Drugs.com. Last updated on Apr 10, 2025.
Note: This document provides detailed information about Pemgarda Side Effects associated with pemivibart. Some dosage forms listed on this page may not apply specifically to the brand name Pemgarda.
Applies to pemivibart: parenteral injection for iv infusion.
Important warnings
This medicine can cause some serious health issues
The American Society of Health-System Pharmacists, Inc. represents that the information provided in the accompanying monograph was formulated with a reasonable standard of care, and in conformity with professional standards in the field.
Readers are cautioned that pemivibart is not an approved treatment for coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, but rather, is being investigated for and is currently available under an FDA emergency use authorization (EUA) for the pre-exposure prophylaxis of COVID-19 in certain adults and adolescents.
The American Society of Health-System Pharmacists, Inc. makes no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to the information contained in the accompanying monograph, and specifically disclaims all such warranties.
Readers of this information are advised that ASHP is not responsible for the continued currency of the information, for any errors or omissions, and/or for any consequences arising from the use of the information contained in the monograph in any and all practice settings.
Readers are advised that decisions regarding use of drugs are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and that the information contained in the monograph is provided for informational purposes only.
The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects.
The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug.
The information contained in the monograph is not a substitute for medical care.
Side effects include:
Most common adverse events (≥2%) in patients with moderate-to-severe immune compromise: systemic and local infusion-related or hypersensitivity reactions, upper respiratory tract infection, viral infection, influenza-like illness, fatigue, headache, and nausea.
See also:
More about Pemgarda (pemivibart)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Patient resources
Professional resources
Further information
Pemgarda side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
